Forte Biosciences Inc
F:37TA

Watchlist Manager
Forte Biosciences Inc Logo
Forte Biosciences Inc
F:37TA
Watchlist
Price: 6.8 EUR Market Closed
Market Cap: 247.8m EUR

Operating Margin
Forte Biosciences Inc

0%
Current
0%
Average
-4.2%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-53.4m
/
Revenue
0

Operating Margin Across Competitors

No Stocks Found

Forte Biosciences Inc
Glance View

Market Cap
247.8m EUR
Industry
Biotechnology

Forte Biosciences, Inc. is a clinical stage biopharmaceutical company focused on dermatology. The company is headquartered in Torrance, California and currently employs 5 full-time employees. The company went IPO on 2017-04-13. The firm is focused on its lead product candidate, FB-401, which is a topical live biotherapeutic for the treatment of inflammatory skin diseases, including pediatric and adult patients with atopic dermatitis (AD). FB401 was developed in collaboration with the National Institutes of Health (NIH), and the National Institute of Allergy and Infectious Diseases (NIAID). FB-401 has completed Phase I/II a testing in adult and pediatric patients with atopic dermatitis.

37TA Intrinsic Value
Not Available
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-53.4m
/
Revenue
0
What is the Operating Margin of Forte Biosciences Inc?

Based on Forte Biosciences Inc's most recent financial statements, the company has Operating Margin of 0%.

Back to Top